Hematology and Oncology - UVMMC Main Campus
111 Colchester Avenue
Main Campus, Main Pavilion, Level 2
Burlington, VT 05401-1473
The University of Vermont Medical Center Cancer Genetics and Prevention program includes a team of medical oncologists, genetic counselors, and other health professionals.
- comprehensive genetic counseling and testing,
- cancer risk assessment
- personalized recommendations for managing cancer risk.
If you have a personal or family history of cancer, you may be eligible for genetic testing to help understand your risk. Your doctor may refer you to the UVM Health Network for genetic counseling and testing. Patients are also welcome to schedule an appointment on their own.
Our program offers:
Experience: The UVM Health Network has been helping individuals and families determine their cancer risk for more than 25 years. Our team includes medical oncologists, genetic counselors and other healthcare professionals. As part of a health system anchored by an academic medical center, our physicians are also leaders, many of whom train the next generation of experts.
Research: The field of cancer genetics is rapidly changing. Our specialists conduct and continuously review research to improve care for patients with hereditary cancer syndromes. Our physicians are active researchers in the field of genetic counseling and testing. A current study follows patients with hereditary cancer syndromes to determine how follow-up affects adherence to prevention strategies.
Access: Our services are available throughout Vermont and northern New York. We offer genetic counseling in person at the UVM Medical Center or remotely via telemedicine. Genetic testing can be performed by blood drawn or with use of a saliva test.
Support: Our compassionate team works to support patients from the time they begin to consider genetic testing through the development of personalized cancer risk assessment and management plan. We can also connect you with local or national support groups.
Follow Up: For patients with hereditary cancer syndromes, such as breast and ovarian cancer syndromes (BRCA1 and BRCA2), Lynch Syndrome and other rare syndromes, we offer longitudinal follow-up care so that patients have access to up-to-date and personalized cancer risk management.
Left to right: Kara Landry, MD, and Marc Greenblatt, MD